Recent studies suggest that specific HLA-DRB1 variants may predict unfavorable disease progression, including an increased risk of radiographic damage and a higher incidence of interstitial lung disease and lymphoproliferative disorders. Here, HLA-DRB1 is linked to lymphoproliferative syndrome.